1. Efficacy and Safety of 2 Doses of OnabotulinumtoxinA for the Treatment of Masseter Muscle Prominence: 6-Month Results From a Randomized, Phase 2b Placebo-Controlled Study. (July 2022) Authors: Fabi, Sabrina; Jones, Derek; Biesman, Brian; Rivkin, Alexander; Garcia, Julia K.; Brandstetter, Tanya; Pan, Grace; Bowen, Beta; Lee, Elisabeth; Brin, Mitchell F. Journal: Toxicon Issue: Volume 214(2022)Supplement 1 Page Start: S60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Masseter Prominence Reduction, Treatment Satisfaction, and Self-Perceived Lower Face Appearance After OnabotulinumtoxinA: Results From a Randomized, Controlled, Phase 2b Trial. (July 2022) Authors: Dayan, Steven; Fabi, Sabrina; Biesman, Brian; Rivkin, Alexander; Lain, Edward; Garcia, Julia K.; Brandstetter, Tanya; Pan, Grace; Bowen, Beta; Lee, Elisabeth; Brin, Mitchell F. Journal: Toxicon Issue: Volume 214(2022)Supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗